Genencor
 | |
| Company type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Founded | 1982 |
| Headquarters | Palo Alto, California, U.S. |
Key people | Tjerk de Ruiter (Chairman & CEO) |
| Products | Purafect, Properase, Spezyme |
| Revenue |  US$380 million (2005) |
Number of employees | 1,500 (2005) |
| Parent | IFF |
| Website | biosciences |
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of IFF.[1] Genencor is a producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982. It is considered to have pioneered the field of industrial biotechnology, as distinct from traditional applications of biotechnology to health care and agriculture.
In 2005 Genencor was acquired by Danisco.[2]
In 2008 Genencor entered a joint venture with DuPont, called DuPont Danisco Cellulosic Ethanol LLC, to develop and commercialize low cost technology for the production of cellulosic ethanol. In 2008, Genencor and Goodyear announced they were working to develop BioIsoprene.
In 2011, DuPont acquired Danisco for $6.3 billion.[3]
In 2021, portions of DuPont including the Genencor division were acquired by International Flavors & Fragrances.[4]
Awards
[edit]Genencor achieved the following awards:[citation needed]
- Named No. 2 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2004)
- Named No. 1 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2005)
- Named No. 1 Best Place to Work in the Bay Area by the San Francisco Chronicle (2005)
- Named No. 11 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2011)
See also
[edit]References
[edit]- ^ DuPont. "DuPont to Acquire Danisco for $6.3 Billion". www.prnewswire.com. Retrieved 2019-07-11.
- ^ Danisco acquire Genencor for $419 million
- ^ Michael J. De La Merced (2011-01-09). "DuPont to Buy Danisco for $5.8 Billion". The New York Times.
DuPont agreed Sunday evening to buy Danisco, a Danish specialty food ingredients maker, for $5.8 billion in cash... as well as assume $500 million of Danisco's debt.
- ^ "IFF to merge with DuPont's $26.2 billion nutrition unit". CNBC. 2019-12-16. Retrieved 2021-02-15.
 | This biotechnology article is a stub. You can help Wikipedia by expanding it. |